Details

Autor(en) / Beteiligte

• Rong, Chunmeng
• Liang, Chenhao
• Shen, Jinze
• Zhang, Yuhua
• Wang, Qurui
• Yang, Fang
• Chen, Yalu
• Luo, Yuqing
• Gu, Meier
• Gao, Panpan
• Xia, Yongming
• Duan, Shiwei

Titel

CLLU1 as an emerging biomarker in chronic lymphoid leukemia

Ist Teil von

• Human cell : official journal of Human Cell Research Society, 2024-05, Vol.37 (3), p.625-632

Ort / Verlag

Singapore: Springer Nature Singapore

Erscheinungsjahr

2024

Link zum Volltext

Quelle

SpringerLink

Beschreibungen/Notizen

• CLLU1, a disease-specific gene associated with chronic lymphoid leukemia (CLL), is located on chromosome 12q22. Previous studies considered CLLU1 to be a non-coding RNA; however, recent research has discovered that its coding sequence region possesses the potential to encode a short peptide similar to interleukin-4. Remarkably, abnormally elevated expression of CLLU1 has only been detected in chronic lymphoid leukemia among all hematological cancers. High CLLU1 expression often indicates more malignant pathological features and an unfavorable prognosis for patients. Importantly, the expression level of CLLU1 remains unaffected by the passage of time or therapeutic interventions, thus rendering it a novel prognostic marker. This article provides a comprehensive summary of relevant research findings on CLLU1 in the context of CLL prognosis and clinical applications, aiming to guide subsequent theoretical and clinical investigations in this field.